Personnel

HIV therapeutics-focused company appoints Neil Graham, MD, chief medical officer

Published in Biotech Business Week, July 11th, 2005

Trimeris, Inc. (TRMS), an HIV therapeutics-focused company, announced the appointment of Neil Graham, MD, as chief medical officer and senior vice president of clinical development and medical affairs.

Graham will be responsible for directing all clinical development and medical affairs activities and will play a vital role in supporting Fuzeon (enfuvirtide) in the marketplace, as well as providing stewardship of pipeline development programs. Lynn Smiley, MD, formerly senior vice president of clinical research, will assume the role of senior vice president of regulatory affairs, compliance, and drug safety.

Graham previously was chief medical...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-07-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry